Works by Inzucchi, Silvio E.
Results: 234
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Metformin in patients with type 2 diabetes and kidney disease: a systematic review.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Metformin in Patients With Type 2 Diabetes and Kidney Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 24, p. 2668, doi. 10.1001/jama.2014.15298
- By:
- Publication type:
- Article
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction : A Post Hoc Analysis of the DAPA-HF Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction: A Post Hoc Analysis of the DAPA-HF Trial.
- Published in:
- Annals of Internal Medicine, 2022, v. 175, n. 6, p. 820, doi. 10.7326/M21-4776
- By:
- Publication type:
- Article
Effect of empagliflozin on myocardial structure and function in patients with type 2 diabetes at high cardiovascular risk: the SIMPLE randomized clinical trial.
- Published in:
- International Journal of Cardiovascular Imaging, 2022, v. 38, n. 3, p. 579, doi. 10.1007/s10554-021-02443-5
- By:
- Publication type:
- Article
Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2017, v. 102, n. 3, p. 914, doi. 10.1210/jc.2016-3237
- By:
- Publication type:
- Article
Response to Comment on Neeland et al. The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial. Diabetes Care 2020;43:3007-3015.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Association of Baseline Characteristics With Insulin Sensitivity and β-Cell Function in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study Cohort.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF.
- Published in:
- 2021
- By:
- Publication type:
- journal article
The Impact of Empagliflozin on Obstructive Sleep Apnea and Cardiovascular and Renal Outcomes: An Exploratory Analysis of the EMPA-REG OUTCOME Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Response to Comment on Flory et al. Reports of Lactic Acidosis Attributed to Metformin, 2015-2018. Diabetes Care 2020;43:244-246.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Reports of Lactic Acidosis Attributed to Metformin, 2015–2018.
- Published in:
- Diabetes Care, 2020, v. 43, n. 1, p. 244, doi. 10.2337/dc19-0923
- By:
- Publication type:
- Article
Retinopathy Outcomes With Empagliflozin Versus Placebo in the EMPA-REG OUTCOME Trial.
- Published in:
- 2019
- By:
- Publication type:
- Letter
A1C Targets Should Be Personalized to Maximize Benefits While Limiting Risks.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial.
- Published in:
- Diabetes Care, 2018, v. 41, n. 2, p. 356, doi. 10.2337/dc17-1096
- By:
- Publication type:
- Article
Cardiovascular Outcomes Trials in Type 2 Diabetes: Where Do We Go From Here? Reflections From a Editors' Expert Forum.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Empagliflozin and Assessment of Lower-Limb Amputations in the EMPA-REG OUTCOME Trial.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? No! Metformin Should Remain the Foundation Therapy for Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Response to Comment on Inzucchi et al. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease. Diabetes Care 2016;39:1684-1692.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluating the Quality of Comprehensive Cardiometabolic Care for Patients With Type 2 Diabetes in the U.S.: The Diabetes Collaborative Registry.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Response to Comment on American Diabetes Association. Approaches to Glycemic Treatment. Sec. 7. In Standards of Medical Care in Diabetes-2016. Diabetes Care 2016;39(Suppl. 1):S52-S59.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.
- Published in:
- Diabetes Care, 2015, v. 38, n. 9, p. 1777, doi. 10.2337/dci15-0012
- By:
- Publication type:
- Article
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140-149.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach.
- Published in:
- Diabetes Care, 2015, v. 38, n. 1, p. 140, doi. 10.2337/dc14-2441
- By:
- Publication type:
- Article
The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy.
- Published in:
- Diabetes Care, 2014, v. 37, n. 7, p. 1924, doi. 10.2337/dc13-2349
- By:
- Publication type:
- Article
Elevated HbA1c and fasting plasma glucose in predicting diabetes incidence among older adults: are two better than one?
- Published in:
- 2013
- By:
- Publication type:
- journal article
Elevated HbA<sub>1c</sub> and Fasting Plasma Glucose in Predicting Diabetes Incidence Among Older Adults.
- Published in:
- Diabetes Care, 2013, v. 36, n. 12, p. 3923, doi. 10.2337/dc12-2631
- By:
- Publication type:
- Article
HbA1c and risk of severe hypoglycemia in type 2 diabetes: the Diabetes and Aging Study.
- Published in:
- 2013
- By:
- Publication type:
- journal article
HbA<sub>1c</sub> and Risk of Severe Hypoglycemia in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2013, v. 36, n. 11, p. 3535, doi. 10.2337/dc13-0610
- By:
- Publication type:
- Article
Pathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action.
- Published in:
- Diabetes Care, 2013, v. 36, n. 7, p. 1807, doi. 10.2337/dc12-2508
- By:
- Publication type:
- Article
Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Personalized Management of Hyperglycemia in Type 2 Diabetes.
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy.
- Published in:
- Diabetes Care, 2013, v. 36, n. 3, p. 565, doi. 10.2337/dc12-0453
- By:
- Publication type:
- Article
Response to Comments on: Inzucchi et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35: 1364-1379.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
- Published in:
- 2012
- By:
- Publication type:
- journal article
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach.
- Published in:
- Diabetes Care, 2012, v. 35, n. 6, p. 1364, doi. 10.2337/dc12-0413
- By:
- Publication type:
- Article
Relationship Between Glycosylated Hemoglobin Assessment and Glucose Therapy Intensification in Patients With Diabetes Hospitalized for Acute Myocardial Infarction.
- Published in:
- Diabetes Care, 2012, v. 35, n. 5, p. 991, doi. 10.2337/dc11-1839
- By:
- Publication type:
- Article
Use of metformin in the setting of mild-to-moderate renal insufficiency.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency.
- Published in:
- Diabetes Care, 2011, v. 34, n. 6, p. 1431, doi. 10.2337/dc10-2361
- By:
- Publication type:
- Article
Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Five-Year Outcomes in High-Risk Participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study.
- Published in:
- Diabetes Care, 2011, v. 34, n. 1, p. 204, doi. 10.2337/dc10-1194
- By:
- Publication type:
- Article
Initial combination therapy with alogliptin and pioglitazone in drug-naïve patients with type 2 diabetes.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Initial Combination Therapy With Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2010, v. 33, n. 11, p. 2406, doi. 10.2337/dc10-0159
- By:
- Publication type:
- Article
The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy.
- Published in:
- 2010
- By:
- Publication type:
- journal article
The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy.
- Published in:
- Diabetes Care, 2010, v. 33, n. 7, p. 1516, doi. 10.2337/dc09-2315
- By:
- Publication type:
- Article
Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes.
- Published in:
- Diabetes Care, 2010, v. 33, n. 6, p. 1395, doi. 10.2337/dc10-0555
- By:
- Publication type:
- Article